The GEO Group, Inc.
The GEO Group, Inc. Q3 FY2025 earnings call
November 7, 2025 · fiscal period ended 2025-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-11-07
Management highlights
- Entered into new or expanded contracts representing over $460 million in new incremental annualized revenues since the beginning of 2025, with facilities like Delaney Hall, North Lake Facility, D. Ray James Facility, North Florida Detention Facility, and reactivation of Adelanto ICE Facility.
- Increased ICE capacity to over 26,000 beds with current census over 22,000.
- Expanded secure transportation services with new contracts for U.S. Marshals and ICE.
- Secured ISAP 5 contract with pricing for 361,000 participants in year 1 and 465,000 in year 2, focusing on technology mix shift and case management services.
- Reduced net debt by approximately $275 million year-to-date, with total net debt at ~$1.4 billion and total net leverage at 3.2x adjusted EBITDA.
- Repurchased ~2 million shares for ~$42 million under stock buyback program, with Board increasing authorization to $500 million.
Segment performance
For the third quarter of 2025, quarterly revenues in owned and leased secure service facilities increased by approximately 22% year-over-year, driven by new ICE contracts. Revenues for nonresidential contracts increased by approximately 10% from the prior year third quarter. Revenues for managed-only contracts increased by approximately 8% from the prior third quarter. Revenues of electronic monitoring and supervision services and reentry centers were largely unchanged from the prior year third quarter. In terms of revenue contribution, owned and leased secure service facilities were a significant contributor due to the activation of new ICE contracts.
Guidance
- Updated Q4 2025 guidance: GAAP net income range $0.23-$0.27 per diluted share, revenues $651M-$676M; adjusted EBITDA between $117M and $127M.
- Full year 2025 guidance: GAAP net income range $1.81-$1.85 per diluted share (including $232M gain on asset sales), adjusted net income $0.84-$0.87 per diluted share on ~$2.6B revenues, adjusted EBITDA $455M-$465M.
- Total capital expenditures for 2025 expected between $200M and $205M.
- Anticipate path to ~$3B in annual revenues in 2026.
Risks
- Department of Homeland Security policy requiring review and approval of contracts above $100,000, time and staff intensive.
- Government shutdown likely delaying new contract awards.
- Need for ICE to recruit more staff to carry out enforcement efforts, time and staff intensive.
Q&A highlights
Q: What's the situation with the government shutdown and ICE population not meeting previous expectations?
A: It's gone slower than expected. Existing facilities are at almost full capacity. Need for additional ICE staff to support new facilities has caused delays, but hope they'll be concluded by end of year.
Q: On the ISAP contract, details on revenue and scaling?
A: $1 billion over 2-year term, year 1 pricing $361M, year 2 $465M. Exact timing of ISAP participant change over time is hard to predict, focus currently on detention.
Q: Commentary on mix shift within ISAP program and guidance?
A: Shift towards more intensive uses like ankle bracelets (higher cost) is happening. Q4 guidance factors in some of this, but more shift expected in next 2 years.
Q: On overall margins and guide, why EBITDA margins not picking up much?
A: Third quarter impacted by costs from starting up contracts, like Adelanto Facility hiring costs. Working to normalize operations, not saying third quarter is new baseline.
Q: When will activated facilities normalize in 2026?
A: Activated facilities this year are assumed to normalize middle of next year, but no specific guidance for 2026 yet.
Q: On electronic monitoring capacity for higher-intensity wearables?
A: Capable of monitoring hundreds of thousands, developing new generation products, and has largest capacity in the world to roll out new devices weekly.
Q: Status of negotiations for remaining idle beds amid government shutdown?
A: Discussions are ongoing, not in formal negotiation stage, but discussions with ICE are continuous.
Q: On ISAP contract length and CapEx?
A: ISAP 5 is a 2-year contract with potential for extensions. There will be some CapEx for monitoring devices as they stock up on devices this year.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
November 7, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.